(Q34345371)

1 August 2017

1 reference

title

Do inhaled corticosteroids inhibit growth in children? (English)

1 reference

1 August 2017

Pedersen S

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

American Journal of Respiratory and Critical Care Medicine

1 August 2017

published in

1 reference

1 August 2017

volume

164

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

521-535

1 reference

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Long-term comparison of three combinations of albuterol, theophylline, and beclomethasone in children with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Fluticasone propionate--an update on preclinical and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Pharmacokinetic optimisation of inhaled steroid therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Lung deposition of aerosol--a comparison of different spacers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Systemic availability and pharmacokinetics of nebulised budesonide in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Systemic activity of inhaled and swallowed beclomethasone dipropionate and the effect of different inhaler devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Inhalers and nebulizers: which to choose and why.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effects of inhaled corticosteroids and inhaled cromolyn sodium on urinary growth hormone excretion in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effects of airway calibre on lung delivery of nebulised salbutamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Regional lung deposition and clearance of 99mTc-labeled beclomethasone-DLPC liposomes in mild and severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Duration of growth suppressive effects of regular inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Analysis of linear growth using a mathematical model. I. From birth to three years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Maturational delay and temporal growth retardation in asthmatic boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Asthma, inhaled corticosteroid treatment, and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Does treatment of asthmatic children with inhaled corticosteroids affect their adult height?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth suppression by glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth and the growth hormone axis in prepubertal children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

The insulin-like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Evaluation of growth rate in height over periods of less than one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Distinctions between short- and long-term human growth studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

On the dynamics of the growth process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

The insulin-like growth factor axis and collagen turnover during prednisolone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Short- and long-term effect of oral salbutamol on growth hormone secretion in prepubertal asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth of asthmatic children during treatment with budesonide: a double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Short term linear growth in asthmatic children during treatment with prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Beclomethasone dipropionate in long-term treatment of asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Safety of 1 year of treatment with budesonide in young children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Treatment of childhood asthma for 13 months and longer with beclomethasone dipropionate aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Long-Term Treatment with Beclomethasone Dipropionate Aerosol in Asthmatic Children, with Special Reference to Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Long-term beclomethasone dipropionate aerosol therapy in juvenile asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Chest deformity, residual airways obstruction and hyperinflation, and growth in children with asthma. II. Significance of chronic chest deformity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Integrated plasma cortisol concentration in children with asthma receiving long‐term inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth retardation after dexamethasone administration: assessment by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Knemometry in children with atopic dermatitis treated with topical glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Reduced height in swedish men with asthma at the age of conscription for military service

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Growth during childhood and final height in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Linear growth in prepubertal children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Adult height in patients with childhood onset atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Attained adult height after childhood asthma: effect of glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Relationships between duration of asthma and asthma severity among children in the Childhood Asthma Management Program (CAMP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Effectiveness of prophylactic inhaled steroids in childhood asthma: A systematic review of the literature☆☆☆★

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Lung Deposition of Inhaled Drugs Increases with Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Knemometry, Urine Cortisol Excretion, and Measures of the Insulin-Like Growth Factor Axis and Collagen Turnover in Children Treated with Inhaled Glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Systemic activity of inhaled topical steroid in toddlers studied by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

The cyclical nature of prepubertal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Dynamic Modeling of Cortisol Reduction after Inhaled Administration of Fluticasone Propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

Has Asthma Medication Use in Children Become More Frequent, More Appropriate, or Both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.164.4.2101050

10.1164/AJRCCM.164.4.2101050

21 January 2018

Identifiers

DOI

1 reference

release_ziftpybvwzgv7iary2ohq42qde

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ziftpybvwzgv7iary2ohq42qde

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference